Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in

It has been over a year since people with multiple sclerosis (pwMS) have been receiving vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With a negligible number of cases in which vaccination led to a relapse or new onset MS, experts around the world agree that the pote...

Descripción completa

Detalles Bibliográficos

Autores principales:	Maura Pugliatti, Hans-Peter Hartung, Celia Oreja-Guevara, Carlo Pozzilli, Laura Airas, Mona Alkhawajah, Nikolaos Grigoriadis, Melinda Magyari, Bart Van Wijmeersch, Magd Zakaria, Ralf Linker, Andrew Chan, Patrick Vermersch, Thomas Berger
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Frontiers Media S.A. 2022-10-01
Colección:	Frontiers in Immunology
Materias:	COVID-19 vaccines SARS-CoV-2 multiple sclerosis disease modifying therapies immune response
Acceso en línea:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1045101/full
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!